A Review of Advances in the Surgical Treatment of Coronary Heart Disease and Lung Cancer
DOI:
https://doi.org/10.59958/hsf.5877Keywords:
coronary heart disease, lung cancer, surgical treatmentAbstract
Lung cancer is currently the most prevalent and fatal malignant tumor in China. Additionally, the incidence of coronary heart disease is steadily increasing. Both diseases exhibit a higher risk of mortality with age, particularly among elderly patients. Moreover, these diseases are interconnected and share common risk factors. However, the treatment options for patients suffering from both lung cancer and coronary heart disease lack clarity and standardized criteria. This article critically examines the literature on surgical interventions for patients with lung cancer complicated by coronary artery disease during the period from January 2021 to December 2022. It summarizes the safety and effectiveness of these interventions and highlights the various surgical options available for different patient profiles.
References
Jiang G, Wang D, Li W, Pan Y, Zheng W, Zhang H, et al. Coronary heart disease mortality in China: age, gender, and urban-rural gaps during epidemiological transition. Revista Panamericana De Salud Publica. 2012; 31: 317–324.
Cao M, Chen W. Epidemiology of lung cancer in China. Thoracic Cancer. 2019; 10: 3–7.
National Health and Health Commission. 2019 China Health and Health Statistics Yearbook. Beijing: Peking Union Medical College Press. 2019.
Li Z, Liu B, Ge W, Zhang W, Gu C, Liu J, et al. Effect of simultaneous surgical treatment of severe coronary artery disease and lung cancer. The Journal of International Medical Research. 2019; 47: 591–599.
Herrero Rivera D, Nieto-Guerrero Gómez JM, Cacicedo Fernández de Bobadilla J, Delgado D, Rivin Del Campo E, Praena-Fernández JM, et al. Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2019; 21: 1220–1230.
Eagle KA, Ginsburg GS, Musunuru K, Aird WC, Balaban RS, Bennett SK, et al. Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation. 2010; 121: 1447–1454.
Ramalho SHR, Shah AM. Lung function and cardiovascular disease: A link. Trends in Cardiovascular Medicine. 2021; 31: 93–98.
Reicher-Reiss H, Jonas M, Goldbourt U, Boyko V, Modan B. Selectively increased risk of cancer in men with coronary heart disease. The American Journal of Cardiology. 2001; 87: 459–62, A6.
Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews. Cancer. 2004; 4: 579–591.
Thukkani AK, Agrawal K, Prince L, Smoot KJ, Dufour AB, Cho K, et al. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. Journal of the American College of Cardiology. 2015; 66: 1091–1101.
Robertson MW, Buth KJ, Stewart KM, Wood JR, Sullivan JA, Hirsch GM, et al. Complete revascularization is compromised in off-pump coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery. 2013; 145: 992–998.
Légaré JF, Hirsch G. Off-pump coronary artery bypass graft surgery is standard of care: where do you stand? The Canadian Journal of Cardiology. 2006; 22: 1107–1110.
Cleveland JC, Jr, Shroyer AL, Chen AY, Peterson E, Grover FL. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. The Annals of Thoracic Surgery. 2001; 72: 1282–1289.
Yoon DW, Shin DW, Cho JH, Lee JH, Yang JH, Han K, et al. Impact of previous percutaneous coronary intervention on cardiovascular outcomes and mortality after lung cancer surgery: A nationwide study in Korea. Thoracic Cancer. 2020; 11: 2517–2528.
Yang Y, Xiao F, Wang J, Song B, Li XH, Li J, et al. Simultaneous surgery in patients with both cardiac and noncardiac diseases. Patient Preference and Adherence. 2016; 10: 1251–1258.
Bablekos GD, Analitis A, Michaelides SA, Charalabopoulos KA, Tzonou A. Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis. Annals of Translational Medicine. 2016; 4: 213.
Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet (London, England). 2007; 369: 667–678.
Sedlis SP, Hartigan PM, Teo KK, Maron DJ, Spertus JA, Mancini GBJ, et al. Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. The New England Journal of Medicine. 2015; 373: 1937–1946.
Fernandez FG, Crabtree TD, Liu J, Meyers BF. Incremental risk of prior coronary arterial stents for pulmonary resection. The Annals of Thoracic Surgery. 2013; 95: 1212–1220.
Groth SS, Rueth NM, Hodges JS, Habermann EB, Andrade RS, D'Cunha J, et al. Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer. The Annals of Thoracic Surgery. 2010; 90: 375–382.
Janssen-Heijnen MLG, van Erning FN, De Ruysscher DK, Coebergh JWW, Groen HJM. Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2015; 26: 902–907.
Powell B, Bolton WD. Management of Lung Cancer with Concomitant Cardiac Disease. Thoracic Surgery Clinics. 2018; 28: 69–79.
Chassot PG, Delabays A, Spahn DR. Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. British Journal of Anaesthesia. 2002; 89: 747–759.
Schoenmakers MCJ, van Boven WJ, van den Bosch J, van Swieten HA. Comparison of on-pump or off-pump coronary artery revascularization with lung resection. The Annals of Thoracic Surgery. 2007; 84: 504–509.
Hollis RH, Graham LA, Richman JS, Deierhoi RJ, Hawn MT. Adverse cardiac events in patients with coronary stents undergoing noncardiac surgery: a systematic review. American Journal of Surgery. 2012; 204: 494–501.
Albaladejo P, Charbonneau H, Samama CM, Collet JP, Marret E, Piriou V, et al. Bleeding complications in patients with coronary stents during non-cardiac surgery. Thrombosis Research. 2014; 134: 268–272.
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 130: 2215–2245.
Wijeysundera DN, Wijeysundera HC, Yun L, Wąsowicz M, Beattie WS, Velianou JL, et al. Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study. Circulation. 2012; 126: 1355–1362.
van Kuijk JP, Flu WJ, Schouten O, Hoeks SE, Schenkeveld L, de Jaegere PPT, et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. The American Journal of Cardiology. 2009; 104: 1229–1234.
Holcomb CN, Hollis RH, Graham LA, Richman JS, Valle JA, Itani KM, et al. Association of Coronary Stent Indication With Postoperative Outcomes Following Noncardiac Surgery. JAMA Surgery. 2016; 151: 462–469.
Marcucci C, Chassot PG, Gardaz JP, Magnusson L, Ris HB, Delabays A, et al. Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting. British Journal of Anaesthesia. 2004; 92: 743–747.
Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, Kobayashi Y, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022. Cardiovascular Intervention and Therapeutics. 2022; 37: 1–34.
Harrison RW, Aggarwal A, Ou FS, Klein LW, Rumsfeld JS, Roe MT, et al. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. The American Journal of Cardiology. 2013; 111: 178–184.
Urschel HC, Jr, Razzuk MA. Median sternotomy as a standard approach for pulmonary resection. The Annals of Thoracic Surgery. 1986; 41: 130–134.
Peters RM, Swain JA. Management of the patient with emphysema, coronary artery disease, and lung cancer. American Journal of Surgery. 1982; 143: 701–705.
Terzi A, Furlan G, Magnanelli G, Conti F, Chiavacci P, Petrilli G, et al. Lung resections concomitant to coronary artery bypass grafting. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 1994; 8: 580–584.
Ciriaco P, Carretta A, Calori G, Mazzone P, Zannini P. Lung resection for cancer in patients with coronary arterial disease: analysis of short-term results. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2002; 22: 35–40.
Voets AJ, Joesoef KS, van Teeffelen ME. Synchroneously occurring lung cancer (stages I-II) and coronary artery disease: concomitant versus staged surgical approach. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 1997; 12: 713–717.
Licker M, de Perrot M, Höhn L, Tschopp JM, Robert J, Frey JG, et al. Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 1999; 15: 314–319.
Tourmousoglou CE, Apostolakis E, Dougenis D. Simultaneous occurrence of coronary artery disease and lung cancer: what is the best surgical treatment strategy? Interactive Cardiovascular and Thoracic Surgery. 2014; 19: 673–681.
Cheng S, Jiang Y, Li X, Lu X, Zhang X, Sun D. Perioperative outcomes of combined heart surgery and lung tumor resection: a systematic review and meta-analysis. Journal of Cardiothoracic Surgery. 2021; 16: 227.
Prokakis C, Koletsis E, Apostolakis E, Panagopoulos N, Charoulis N, Velissaris D, et al. Combined heart surgery and lung tumor resection. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2008; 14: CS17–21.
Patanè F, Verzini A, Zingarelli E, di Summa M. Simultaneous operation for cardiac disease and lung cancer. Interactive Cardiovascular and Thoracic Surgery. 2002; 1: 69–71.
Oh HC, Han JW, Choi JW, Kim YH, Hwang HY, Kim KB. Concomitant off-pump coronary artery bypass and non-cardiovascular surgery. Journal of Thoracic Disease. 2016; 8: 2115–2120.
Kanzaki R, Kimura T, Kawamura T, Funaki S, Shintani Y, Minami M, et al. Treatment of simultaneously discovered lung cancer and cardiovascular disease: a 20-year single-institution experience. Surgery Today. 2017; 47: 726–732.
Liu B, Chen C, Gu C, Li Q, Liu J, Pu Y, et al. Combined Coronary Artery Bypass Graft (CABG) Surgery and Lung Resection for Lung Cancer in Patients More than 50 Years-of-Age. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2018; 24: 3307–3314.
Danton MH, Anikin VA, McManus KG, McGuigan JA, Campalani G. Simultaneous cardiac surgery with pulmonary resection: presentation of series and review of literature. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 1998; 13: 667–672.
Sablotzki A, Welters I, Lehmann N, Menges T, Görlach G, Dehne M, et al. Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-beta in patients undergoing coronary artery bypass grafting. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 1997; 11: 763–768.
Markewitz A, Lante W, Franke A, Marohl K, Kuhlmann WD, Weinhold C. Alterations of cell-mediated immunity following cardiac operations: clinical implications and open questions. Shock (Augusta, Ga.). 2001; 16: 10–15.
Byrne JG, Leacche M, Agnihotri AK, Paul S, Bueno R, Mathisen DJ, et al. The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies: a 10-year two-center experience. Chest. 2004; 125: 1581–1586.
Cao Z, Huang H, Zhou Y, Li Y, Ma Y, Zhou N. Efficacy of on-pump coronary artery bypass grafting and stent implantation combined with surgery on lung cancer. Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology. 2019; 24: 2253–2259.
Partrick DA, Moore EE, Fullerton DA, Barnett CC, Jr, Meldrum DR, Silliman CC. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. The Journal of Surgical Research. 1999; 86: 42–49.
Boyle EM, Jr, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. The Annals of Thoracic Surgery. 1997; 63: 277–284.
Tschernko EM, Bambazek A, Wisser W, Partik B, Jantsch U, Kubin K, et al. Intrapulmonary shunt after cardiopulmonary bypass: the use of vital capacity maneuvers versus off-pump coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery. 2002; 124: 732–738.
Taylor KM. Central nervous system effects of cardiopulmonary bypass. The Annals of Thoracic Surgery. 1998; 66: S20–S28.
Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. The Annals of Thoracic Surgery. 1999; 68: 1107–1115.
Jensen RH, Storgaard M, Vedelsdal R, Obel N. Impaired neutrophil chemotaxis after cardiac surgery. Scandinavian Journal of Thoracic and Cardiovascular Surgery. 1995; 29: 115–118.
Van Dijk D, Jansen EWL, Hijman R, Nierich AP, Diephuis JC, Moons KGM, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. JAMA. 2002; 287: 1405–1412.
Onorati F, Rubino AS, Nucera S, Foti D, Sica V, Santini F, et al. Off-pump coronary artery bypass surgery versus standard linear or pulsatile cardiopulmonary bypass: endothelial activation and inflammatory response. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2010; 37: 897–904.
Brutel de la Rivière A, Knaepen P, Van Swieten H, Vanderschueren R, Ernst J, Van den Bosch J. Concomitant open heart surgery and pulmonary resection for lung cancer. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 1995; 9: 310–314.
Yeginsu A, Vayvada M, Karademir BC, Erkılınç A, Tasci AE, Buyukbayrak F, et al. Combined Off-Pump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease. Brazilian Journal of Cardiovascular Surgery. 2018; 33: 483–489.
Piehler JM, Trastek VF, Pairolero PC, Pluth JR, Danielson GK, Schaff HV, et al. Concomitant cardiac and pulmonary operations. The Journal of Thoracic and Cardiovascular Surgery. 1985; 90: 662–667.
Saxena P, Tam RKW. Combined off-pump coronary artery bypass surgery and pulmonary resection. The Annals of Thoracic Surgery. 2004; 78: 498–501.
Canver CC, Bhayana JN, Lajos TZ, Raza ST, Lewin AN, Bergsland J, et al. Pulmonary resection combined with cardiac operations. The Annals of Thoracic Surgery. 1990; 50: 796–799.
Rosalion A, Woodford NW, Clarke CP, Buxton B. Concomitant coronary revascularization and resection of lung cancer. The Australian and New Zealand Journal of Surgery. 1993; 63: 336–340.
Yokoyama T, Derrick MJ, Lee AW. Cardiac operation with associated pulmonary resection. The Journal of Thoracic and Cardiovascular Surgery. 1993; 105: 912–917.
Dyszkiewicz W, Jemielity MM, Piwkowski CT, Perek B, Kasprzyk M. Simultaneous lung resection for cancer and myocardial revascularization without cardiopulmonary bypass (off-pump coronary artery bypass grafting). The Annals of Thoracic Surgery. 2004; 77: 1023–1027.
Ma XC, Ou SL, Zhang ZT, Hu YS, Song FQ. Outcomes of combined pulmonary resection and off-pump coronary artery bypass grafting for patients with lung tumor and concurrent coronary heart disease. Zhonghua Yi Xue Za Zhi. 2012; 92: 3134–3136.
Ma X, Huang F, Zhang Z, Song F, Ou S. Lung cancer resection with concurrent off-pump coronary artery bypasses: safety and efficiency. Journal of Thoracic Disease. 2016; 8: 2038–2045.
Takahashi T, Nakano S, Shimazaki Y, Kaneko M, Nakahara K, Miyata M, et al. Concomitant coronary bypass grafting and curative surgery for cancer. Surgery Today. 1995; 25: 131–135.
Darwazah AK, Sham'a RAHA, Isleem I, Hanbali B, Jaber B. Off-pump coronary artery bypass for emergency myocardial revascularization. Asian Cardiovascular & Thoracic Annals. 2009; 17: 133–138.
Ivanov J, Borger MA, Tu JV, Rao V, David TE. Mid-term outcomes of off-pump versus on-pump coronary artery bypass graft surgery. The Canadian Journal of Cardiology. 2008; 24: 279–284.
Hasegawa S, Otake Y, Bando T, Cho H, Inui K, Wada H. Pulmonary dissemination of tumor cells after extended resection of thyroid carcinoma with cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery. 2002; 124: 635–636.
Arom KV, Flavin TF, Emery RW, Kshettry VR, Janey PA, Petersen RJ. Safety and efficacy of off-pump coronary artery bypass grafting. The Annals of Thoracic Surgery. 2000; 69: 704–710.
Tempe DK, Gandhi A, Virmani S. Resource utilization in on- and off-pump coronary artery surgery: factors influencing postoperative length of stay--an experience of 1746 consecutive patients undergoing fast-track cardiac anesthesia. Journal of Cardiothoracic and Vascular Anesthesia. 2006; 20: 128; author reply 128–9.
Hoff SJ, Ball SK, Coltharp WH, Glassford DM, Jr, Lea JW, 4th, Petracek MR. Coronary artery bypass in patients 80 years and over: is off-pump the operation of choice? The Annals of Thoracic Surgery. 2002; 74: S1340–S1343.
Hirose H, Amano A, Takahashi A. Off-pump coronary artery bypass grafting for elderly patients. The Annals of Thoracic Surgery. 2001; 72: 2013–2019.
Sharony R, Bizekis CS, Kanchuger M, Galloway AC, Saunders PC, Applebaum R, et al. Off-pump coronary artery bypass grafting reduces mortality and stroke in patients with atheromatous aortas: a case control study. Circulation. 2003; 108: II15–II20.
Sharony R, Grossi EA, Saunders PC, Galloway AC, Applebaum R, Ribakove GH, et al. Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease. The Journal of Thoracic and Cardiovascular Surgery. 2004; 127: 406–413.
Puskas JD, Kilgo PD, Kutner M, Pusca SV, Lattouf O, Guyton RA. Off-pump techniques disproportionately benefit women and narrow the gender disparity in outcomes after coronary artery bypass surgery. Circulation. 2007; 116: I192–I199.
Bittner HB, Savitt MA. Off-pump coronary artery bypass grafting decreases morbidity and mortality in a selected group of high-risk patients. The Annals of Thoracic Surgery. 2002; 74: 115–118.
Ascione R, Reeves BC, Rees K, Angelini GD. Effectiveness of coronary artery bypass grafting with or without cardiopulmonary bypass in overweight patients. Circulation. 2002; 106: 1764–1770.
Meharwal ZS, Mishra YK, Kohli V, Bapna R, Singh S, Trehan N. Off-pump multivessel coronary artery surgery in high-risk patients. The Annals of Thoracic Surgery. 2002; 74: S1353–S1357.
Gaudino M, Glieca F, Alessandrini F, Nasso G, Pragliola C, Luciani N, et al. High risk coronary artery bypass patient: incidence, surgical strategies, and results. The Annals of Thoracic Surgery. 2004; 77: 574–9; discussion 580.
Gaudino M, Angelini GD, Antoniades C, Bakaeen F, Benedetto U, Calafiore AM, et al. Off-Pump Coronary Artery Bypass Grafting: 30 Years of Debate. Journal of the American Heart Association. 2018; 7: e009934.
Puskas JD, Thourani VH, Kilgo P, Cooper W, Vassiliades T, Vega JD, et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. The Annals of Thoracic Surgery. 2009; 88: 1142–1147.
Puskas JD, Edwards FH, Pappas PA, O'Brien S, Peterson ED, Kilgo P, et al. Off-pump techniques benefit men and women and narrow the disparity in mortality after coronary bypass grafting. The Annals of Thoracic Surgery. 2007; 84: 1447–1456.
Locker C, Mohr R, Paz Y, Kramer A, Lev-Ran O, Pevni D, et al. Myocardial revascularization for acute myocardial infarction: benefits and drawbacks of avoiding cardiopulmonary bypass. The Annals of Thoracic Surgery. 2003; 76: 771–777.
Ahmed AA, Sarsam MA. Off-pump combined coronary artery bypass grafting and left upper lobectomy through left posterolateral thoracotomy. The Annals of Thoracic Surgery. 2001; 71: 2016–2018.
Omran N, Habal P, Mandak J, Chek JL. Broncho-pleural fistula following vacuum-assisted closure therapy. Journal of Cardiac Surgery. 2013; 28: 397–398.
Peters RM, Wellons HA, Jr, Htwe TM. Total compliance and work of breathing after thoracotomy. The Journal of Thoracic and Cardiovascular Surgery. 1969; 57: 348–355.
Al-Attar N, Salvi S, Sebbag U, Nataf P. Combined left pneumonectomy and off-pump coronary artery bypass through left thoracotomy. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2001; 19: 226–228.
Wang Z, Guo F, Li J, Sun D. Safety and efficacy of lobectomy combined with off-pump coronary artery bypass grafting for lung cancer. Journal of Thoracic Disease. 2021; 13: 4438–4447.
Onaitis MW, Petersen RP, Balderson SS, Toloza E, Burfeind WR, Harpole DH, Jr, et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Annals of Surgery. 2006; 244: 420–425.
Paul S, Altorki NK, Sheng S, Lee PC, Harpole DH, Onaitis MW, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. The Journal of Thoracic and Cardiovascular Surgery. 2010; 139: 366–378.
Izbicki JR, Thetter O, Habekost M, Karg O, Passlick B, Kubuschok B, et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. The British Journal of Surgery. 1994; 81: 229–235.
Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143: e278S–e313S.
Han H, Chen H. Selective lymph node dissection in early-stage non-small cell lung cancer. Journal of Thoracic Disease. 2017; 9: 2102–2107.
Kaku R, Teramoto K, Ishida K, Igarashi T, Hashimoto M, Kitamura S, et al. Simultaneous resection of pulmonary tumor following cardiovascular surgery. Asian Journal of Surgery. 2017; 40: 123–128.
Dyszkiewicz W, Jemielity M, Piwkowski C, Kasprzyk M, Perek B, Gasiorowski L, et al. The early and late results of combined off-pump coronary artery bypass grafting and pulmonary resection in patients with concomitant lung cancer and unstable coronary heart disease. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2008; 34: 531–535.
Mishra PK, Pandey R, Shackcloth MJ, McShane J, Grayson AD, Carr MH, et al. Cardiac comorbidity is not a risk factor for mortality and morbidity following surgery for primary non-small cell lung cancer. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2009; 35: 439–443.
Birim O, Kappetein AP, Waleboer M, Puvimanasinghe JPA, Eijkemans MJC, Steyerberg EW, et al. Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode. The Journal of Thoracic and Cardiovascular Surgery. 2006; 132: 491–498.
Liu W, Huang Q, Lin D, Zhao L, Ma J. Effect of lung protective ventilation on coronary heart disease patients undergoing lung cancer resection. Journal of Thoracic Disease. 2018; 10: 2760–2770.
Tsubochi H, Shibano T, Endo S. Recommendations for perioperative management of lung cancer patients with comorbidities. General Thoracic and Cardiovascular Surgery. 2018; 66: 71–80.
Takamochi K, Oh S, Matsuoka J, Suzuki K. Risk factors for morbidity after pulmonary resection for lung cancer in younger and elderly patients. Interactive Cardiovascular and Thoracic Surgery. 2011; 12: 739–743.
Puskas JD, Williams WH, Duke PG, Staples JR, Glas KE, Marshall JJ, et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery. 2003; 125: 797–808.
Knipp SC, Matatko N, Wilhelm H, Schlamann M, Massoudy P, Forsting M, et al. Evaluation of brain injury after coronary artery bypass grafting. A prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2004; 25: 791–800.
